Farmson Pharmaceuticals is the world’s largest manufacturer of API Paracetamol, and this achievement is a result of their three state-of-the-art manufacturing facilities, qualified personnel, and proactive management team. The company has made significant investments in research and development, and their best-in-class lab facilities and R&D center have enabled them to conduct various research studies, leading to the development of high-quality products. Read more : https://www.farmson.com/blogs/farmson-manufacturing-facilities/
Farmson was established in the year 1971 for manufacturing of Paracetamol through phenol route. In the year 2000, we switched over to the PNCB route to manufacture Paracetamol. Currently, we are the GLOBAL LEADER in API Paracetamol production.
Wednesday, 26 July 2023
Farmson manufacturing facilities for API Paracetamol
Farmson Pharmaceuticals is the world’s largest manufacturer of API Paracetamol, and this achievement is a result of their three state-of-the-art manufacturing facilities, qualified personnel, and proactive management team. The company has made significant investments in research and development, and their best-in-class lab facilities and R&D center have enabled them to conduct various research studies, leading to the development of high-quality products. Read more : https://www.farmson.com/blogs/farmson-manufacturing-facilities/
Subscribe to:
Post Comments (Atom)
Research & Development - Driving Innovation at Farmson
Research & Development is the engine behind Farmson’s long-term success in pharmaceutical manufacturing. With a dedicated, state-of-the-...
-
Farmson Basic Drugs is expanding beyond paracetamol with a growing portfolio of high-demand APIs across respiratory, cardiovascular, urology...
-
Farmson has expanded beyond Paracetamol to become a world-class manufacturer of Caffeine API with a dedicated, state-of-the-art synthetic ca...
-
Farmson Basic Drugs, a leader in API manufacturing, expands its innovation with a world-class synthetic caffeine facility designed for pharm...

No comments:
Post a Comment